RALEIGH, N.C. , May 21, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO ( Contract Commercial Organization ), today announced that Chief Executive Officer Alistair
Highlights Combined Company ASC 605 net new business awards of $872.1 million for the first quarter of 2018 representing a book-to-bill ratio of 1.15x. — Clinical Solutions awards of $549.7 million , resulting in first quarter of 2018 and trailing 12-month book-to-bill ratios of 1.04x and 1.21x,
Meggs Served as Interim CFO Since February 2018 RALEIGH, N.C. , May 09, 2018 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), a leading biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO ( Contract Commercial Organization ), today announced that
RALEIGH, N.C. , May 03, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and CCO ( Contract Commercial Organization ), today announced that Amy J.
New Network Builds on Success of the Company’s Early Phase, Oncology, Psychiatry and Vaccine Catalyst Site Networks RALEIGH, N.C. , April 30, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the launch of the
RALEIGH, N.C. , April 17, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO and CCO ( Contract Commercial Organization ), will release its first quarter 2018 financial results on Wednesday, May 9, 2018 , prior
Syneos Health Joins Align Clinical CRO as Founding Member to Continue the Company’s Focus on Shortening the Distance from Lab to Life™ RALEIGH, N.C. , March 27, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced
RALEIGH, N.C. , March 06, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the Barclays Global Healthcare Conference in Miami . Mr.
Highlights Combined Company net new business awards of $622.9 million for the fourth quarter and $2.55 billion for the full year 2017 representing growth of 16.5% for the full year 2017. Combined Company book-to-bill ratio of 1.16x for the fourth quarter and 1.20x for the full year 2017.
RALEIGH, N.C. , Feb. 08, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, has announced the appointment of Lisa van Capelle as Chief Human Resources Officer (CHRO). van Capelle will guide a workforce of approximately 21,000
New Data from Global Survey Reveals Expectations and Concerns of Patients and Caregivers Confronting a Future with Artificial Intelligence RALEIGH, N.C. , Feb. 06, 2018 (GLOBE NEWSWIRE) -- Syneos Health Communications today released a report that provides pioneering perspectives into patients’
RALEIGH, N.C. , Feb. 01, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and year end 2017 financial results on Wednesday, February 28, 2018 , prior to its earnings call at 8:00 a.m.
Joining Forces Brings Unparalleled Talent Together Under Top Leadership, Drives Scale for East Coast Operations and Expands West Coast Biopharma and Medtech Offerings RALEIGH, N.C. , Jan. 22, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (NASDAQ:SYNH), the only fully integrated biopharmaceutical
The Commercial Forecast Joins a Series of Consumer, Digital, Communications and Healthcare Trends Reports that Reveals Shifts in Media and Medicine Impacting Stakeholder Engagement RALEIGH, N.C. , Jan. 10, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (NASDAQ:SYNH), the only fully integrated
New Identity Signifies Industry’s Only Fully Integrated, End-to-End Biopharmaceutical Solutions Organization RALEIGH, N.C. , Jan. 04, 2018 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR) today announced it has changed its brand identity to Syneos Health, Inc.
Greg Rush to Step Down as Chief Financial Officer to Pursue Another Opportunity RALEIGH, N.C. , Jan. 03, 2018 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization, today announced that Greg Rush is stepping down as Chief
